Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Epileptogenesis in organotypic hippocampal cultures has limited dependence on culture medium composition.

Liu J, Saponjian Y, Mahoney MM, Staley KJ, Berdichevsky Y.

PLoS One. 2017 Feb 22;12(2):e0172677. doi: 10.1371/journal.pone.0172677. eCollection 2017.

2.

Neuropathology of SUDEP: Role of inflammation, blood-brain barrier impairment, and hypoxia.

Michalak Z, Obari D, Ellis M, Thom M, Sisodiya SM.

Neurology. 2017 Feb 7;88(6):551-561. doi: 10.1212/WNL.0000000000003584. Epub 2017 Jan 13.

3.

Inflammation in epileptogenesis after traumatic brain injury.

Webster KM, Sun M, Crack P, O'Brien TJ, Shultz SR, Semple BD.

J Neuroinflammation. 2017 Jan 13;14(1):10. doi: 10.1186/s12974-016-0786-1. Review.

4.

Astrocytic TLR4 at the crossroads of inflammation and seizure susceptibility.

Henneberger C, Steinhäuser C.

J Cell Biol. 2016 Dec 5;215(5):607-609. Epub 2016 Nov 23.

PMID:
27881712
5.

Infiltrating monocytes promote brain inflammation and exacerbate neuronal damage after status epilepticus.

Varvel NH, Neher JJ, Bosch A, Wang W, Ransohoff RM, Miller RJ, Dingledine R.

Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):E5665-74. doi: 10.1073/pnas.1604263113. Epub 2016 Sep 6.

6.

Neuronal uptake of serum albumin is associated with neuron damage during the development of epilepsy.

Liu Z, Liu J, Wang S, Liu S, Zhao Y.

Exp Ther Med. 2016 Aug;12(2):695-701. Epub 2016 May 26.

7.

Cerebrospinal fluid analysis after unprovoked first seizure.

Zisimopoulou V, Mamali M, Katsavos S, Siatouni A, Tavernarakis A, Gatzonis S.

Funct Neurol. 2016 Apr-Jun;31(2):101-7.

8.

Albumin and multiple sclerosis.

LeVine SM.

BMC Neurol. 2016 Apr 12;16:47. doi: 10.1186/s12883-016-0564-9. Review.

9.

Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to Bedside.

Dey A, Kang X, Qiu J, Du Y, Jiang J.

Trends Pharmacol Sci. 2016 Jun;37(6):463-84. doi: 10.1016/j.tips.2016.03.001. Epub 2016 Apr 6. Review.

PMID:
27062228
10.

Aberrant excitatory rewiring of layer V pyramidal neurons early after neocortical trauma.

Takahashi DK, Gu F, Parada I, Vyas S, Prince DA.

Neurobiol Dis. 2016 Jul;91:166-81. doi: 10.1016/j.nbd.2016.03.003. Epub 2016 Mar 5.

PMID:
26956396
11.

Defining the therapeutic time window for suppressing the inflammatory prostaglandin E2 signaling after status epilepticus.

Du Y, Kemper T, Qiu J, Jiang J.

Expert Rev Neurother. 2016;16(2):123-30. doi: 10.1586/14737175.2016.1134322. Epub 2016 Jan 13. Review.

12.

Computational and Pharmacological Target of Neurovascular Unit for Drug Design and Delivery.

Islam MM, Mohamed Z.

Biomed Res Int. 2015;2015:731292. doi: 10.1155/2015/731292. Epub 2015 Oct 22. Review.

13.

Brain endothelial TAK1 and NEMO safeguard the neurovascular unit.

Ridder DA, Wenzel J, Müller K, Töllner K, Tong XK, Assmann JC, Stroobants S, Weber T, Niturad C, Fischer L, Lembrich B, Wolburg H, Grand'Maison M, Papadopoulos P, Korpos E, Truchetet F, Rades D, Sorokin LM, Schmidt-Supprian M, Bedell BJ, Pasparakis M, Balschun D, D'Hooge R, Löscher W, Hamel E, Schwaninger M.

J Exp Med. 2015 Sep 21;212(10):1529-49. doi: 10.1084/jem.20150165. Epub 2015 Sep 7.

14.

Adenosinergic signaling in epilepsy.

Boison D.

Neuropharmacology. 2016 May;104:131-9. doi: 10.1016/j.neuropharm.2015.08.046. Epub 2015 Sep 1. Review.

PMID:
26341819
15.

Identification of a neurovascular signaling pathway regulating seizures in mice.

Fredriksson L, Stevenson TK, Su EJ, Ragsdale M, Moore S, Craciun S, Schielke GP, Murphy GG, Lawrence DA.

Ann Clin Transl Neurol. 2015 Jul;2(7):722-38. doi: 10.1002/acn3.209. Epub 2015 May 1.

16.

Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex.

Zhang B, Zou J, Rensing NR, Yang M, Wong M.

Neurobiol Dis. 2015 Aug;80:70-9. doi: 10.1016/j.nbd.2015.04.016. Epub 2015 May 21.

17.

Albumin induces excitatory synaptogenesis through astrocytic TGF-β/ALK5 signaling in a model of acquired epilepsy following blood-brain barrier dysfunction.

Weissberg I, Wood L, Kamintsky L, Vazquez O, Milikovsky DZ, Alexander A, Oppenheim H, Ardizzone C, Becker A, Frigerio F, Vezzani A, Buckwalter MS, Huguenard JR, Friedman A, Kaufer D.

Neurobiol Dis. 2015 Jun;78:115-25. doi: 10.1016/j.nbd.2015.02.029. Epub 2015 Mar 30.

18.

Anatomy and physiology of the blood-brain barrier.

Serlin Y, Shelef I, Knyazer B, Friedman A.

Semin Cell Dev Biol. 2015 Feb;38:2-6. doi: 10.1016/j.semcdb.2015.01.002. Epub 2015 Feb 11. Review.

19.

Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticus.

Jiang J, Yang MS, Quan Y, Gueorguieva P, Ganesh T, Dingledine R.

Neurobiol Dis. 2015 Apr;76:126-36. doi: 10.1016/j.nbd.2014.12.032. Epub 2015 Jan 17.

20.

Gliomas and the vascular fragility of the blood brain barrier.

Dubois LG, Campanati L, Righy C, D'Andrea-Meira I, Spohr TC, Porto-Carreiro I, Pereira CM, Balça-Silva J, Kahn SA, DosSantos MF, Oliveira Mde A, Ximenes-da-Silva A, Lopes MC, Faveret E, Gasparetto EL, Moura-Neto V.

Front Cell Neurosci. 2014 Dec 12;8:418. doi: 10.3389/fncel.2014.00418. eCollection 2014. Review.

Supplemental Content

Support Center